Andy Obermueller
Government-Driven Investing
Keith Fitz-Gerald
New China Trader
Marvin Appel
Systems & Forecasts
Jim Powell
Global Changes & Opportunities Report
by Mike Cintolo, editor Cabot Market Letter

Mike CintoloWe remain as enthusiastic as ever about the fundamental story for Las Vegas Sands (LVS).

Investors know the general story, but we feel many are underestimating the potential growth.

Read more...
Get our Daily Digest in your Inbox.
Top stock ideas from the nation's leading advisors.
by Geoffrey Seiler, editor BullMarket.com

Geoffrey SeilerCree (CREE) is a leading provider of light-emitting diodes (LED) and related technology.

In my view, the company is in an excellent position to benefit from the "Green Revolution" taking place in the lighting industry.

Read more...
by Mark Salzinger, editor The No-Load Fund Investor

Mark SalzingerWhile traditionally many investors worry about the potential effects of runaway inflation on stock prices, lately others worry more about the potential effects of deflation, a falling price level.

There’s certainly plenty of common sense behind worries that either deflation or significant inflation would be bad for equity prices. But does the history of stock prices agree?

Read more...
by Mark Skousen, editor Forecasts & Strategies

Mark SkousenWe do have a select number of speculative stocks and growth funds in our portfolio. Among them, my favorite is Ford Motor Co. (F).

The stock, which has been my favorite speculation for 2010, reported another blockbuster quarter.

Read more...
by Dr. Melvin Pasternak, editor Double-Digit Trading

Dr. Melvin PasternakWhat's the link between Kingsford charcoal, Hidden Valley salad dressing, Brita water filtration systems, Glad garbage bags and Burt's Bees personal care products?

Surprisingly, these diverse products are all brands of Clorox (CLX) -- thought of by many people as "the bleach company."

Read more...
by John McCamant, editor The Medical Technology Stock Letter

John McCamantImmunoGen (IMGN) saw a huge decline after they and Roche announced they have received a Refuse to File (RTF) letter from the FDA.

The refusal letter was for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010.

Read more...
by Chuck Carlson, editor The DRIP Investor

Chuck CarlsonIn a number of respects, Motorola (MOT) is the quintessential  “special situations” stock.

I like the various investment angles — company break up, asset sales, buying by a big insider, a reenergized product line.

Read more...
by Paul Goodwin, editor Cabot China & Emerging Markets Report

Paul GoodwinFertilizer companies are thriving in China. And the fastest growth is in the area of organic fertilizers, which are encouraged by the Chinese government.  

Which brings us to China Agritech (CAGC), a major manufacturer of organic fertilizer.

Read more...
by Bernie Schaeffer, editor Schaeffer's Investment Research

Bernie SchaefferMy long and short positions are selected based on a combination of fundamental, technical and sentiment-based metrics.

My latest long positions are in Aruba Networks (ARUN) and Advance Auto Parts (AAP), while my most recent short position is in NVIDIA (NVDA).

Read more...
by Carla Pasternak, editor High-Yield Investing

Carla PasternakThe Cushing MLP Total Return Fund (SRV)  is a closed-end fund that invests in master limited partnerships (MLPs), MLP bonds, and natural resource companies that are not publicly traded.

In addition to providing diversification, SRV provides a huge advantage over investing in individual MLPs.

Read more...
by Jim Lowell, editor Fidelity Investor

Jim LowellFidelity Select Health Care (FSPHX) is our latest Fidelity fund spotlight feature.

The fund continues to be a clear market overweight position for our fundamentally-driven portfolios.

Read more...
by Karim Rahemtulla, contributing editor White Cap Research Group

Karim RahemtullaVisa (V) has been around for decades and the company process billions of transactions a year.

And each time a card is swiped, they get a cut; and since Visa only processes the payment, the actual liability rests with the issuing bank. Not a bad deal.

Read more...
by Stephen Leeb, editor The Complete Investor

Stephen LeebGrowth Portfolio member and the largest retailer in the world Wal-Mart (WMT) just reported its second-quarter results.

Earnings per share were up 9 percent – and, more important, the company increased its EPS guidance for the full year; the company is now expecting to make from $3.95 to $4.05, exceeds its earlier forecast of $4 profit for the year.

Read more...



News Flash

Geron (GERN)
Steve Christ, The Wealth Advisory

In a recent 15-page ruling, a U.S. judge ruled that using taxpayer dollars to fund embryonic stem cell research violates a 1996 law; but in the case of Geron Corp. (GERN), the company won’t be affected at all.


Read more...

 

Industrial trio: BWA, TEN, DXPE
Stephen Quickel, US Investment Report

Among our new stock are three industrials that expected to grow earnings by 30% a year: Borg Warner (BWA), Tenneco (TEN) and DXP Enterprises (DXPE).


Read more...


Banner
Banner
   

Bullion Monarch Mining (BULM)
Max Bowser, The Bowser Report

Bullion Monarch Mining (BULM) -- a holding in our "penny stock" portfolio -- recorded its best revenue year ever.


Read more...

 

Global X Lithium ETF (LIT)
Jim Trippon, ETF Profit Report

It’s rare that we would recommend an ETF that is as new as Global X Lithium (LIT), but with the market taking a tumble, we believe we’re getting good value on this newly-minted vehicle.


Read more...

 

Consumer Staples (XLP)
by Doug Fabian, Making Money Alert

The Consumer Staples Select Sector SPDR (XLP) is an ETF that tracks companies that have products that people need in both good and bad economic times.


Read more...

 

WisdomTree SmallCap Dividend (DES)
by Walter Frank, MoneyLetter

WisdomTree SmallCap Dividend (DES), which sports an attractive 4.3% yield, has been added to our fund coverage.


Read more...

 

Closed-end income favorites
by Harry Domash, Dividend Detective

The latest new positions in our closed-end fund portfolio are Guggenheim Emerging Opportunity (GOF) and First Trust/Aberdeen Emerging Opportunity (FEO).


Read more...

 

Quality trio: XOM, GOOG, JNJ
by Adam Sharp, contributing editor Wealth Daily

Buying defensive blue chips makes sense. Three of my favorites are ExxonMobil (XOM), Johnson and Johnson (JNJ) and Google (GOOG).


Read more...

 

Xcel Energy (XEL)
by Roger Conrad, The Utility Forecaster

In late 2002 Xcel Energy (XEL) was on the brink of Chapter 11; it has since come back, recently earning a credit upgrade from S&P to A- with an "excellent" risk profile.


Read more...

 

Virginia Mines (VGQ)
by Adrian Day, The Global Analyst

Virginia Mines (VGQ) remains one of a handful of my favorite companies; the company continues ongoing rationalization of its extensive mining property portfolio.


Read more...